Adlai Nortye is a global clinical-stage biotechnology company focused on transforming deadly cancers into chronic and eventually curable diseases. With research and development centers in the U. S.

and China, we are dedicated to the discovery and development of innovative cancer therapies for a variety of tumor types. Our experienced management team has curated a distinctive oncology pipeline and established partnerships with leading pharmaceutical companies to accelerate drug discovery and development. We are committed to becoming an innovative biopharmaceutical company with a global footprint, striving to benefit patients worldwide.

Our mission is to push the boundaries of cancer treatment and to improve patient outcomes. At Adlai Nortye, we are driven by the relentless pursuit of cutting-edge cancer treatments and are dedicated to making a meaningful impact on the lives of patients. For more information, visit our website or contact us directly